Physician

Rachel Wenner Ruzanic, M.D.

According to 2025 Medicare claims, Rachel Ruzanic, M.D. (NPI: 1073708608) practices dermatology in the St. Cloud, MN market, with the plurality of this provider's patient population coming from Stearns, MN. This provider's primary affiliated billing organization is CENTRACARE CLINIC (NPI: 1407858020; TIN: 411806657) and primary practice location at 56303-1116. Ruzanic is affiliated with the Central Minnesota ACO, LLC (ACO ID: A2844), participating under the MSSP model.

Ruzanic's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 437 traditional Medicare patients, billed 2,213 HCPCS/CPT codes, and received $118,994 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 990 prescription claims across 340 beneficiaries totaling $1,035,921 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $106,101 and ending at $118,994. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $233,126 to $1,035,921. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$92K$185K2015 Medicare payment: $106,101 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $97,731 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $92,214 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $73,924 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $184,770 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $136,804 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $178,301 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $127,564 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $129,254 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $118,994 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153002,212$106,101
20163402,012$97,731
20173261,638$92,214
20183341,593$73,924
20195873,352$184,770
20205202,916$136,804
20215513,131$178,301
20224852,581$127,564
20234722,609$129,254
20244372,213$118,994

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$518K$1.0M2015 Drug cost: $233,126 (USD; Tot_Drug_Cst)2016 Drug cost: $342,251 (USD; Tot_Drug_Cst)2017 Drug cost: $266,156 (USD; Tot_Drug_Cst)2018 Drug cost: $394,930 (USD; Tot_Drug_Cst)2019 Drug cost: $493,541 (USD; Tot_Drug_Cst)2020 Drug cost: $570,710 (USD; Tot_Drug_Cst)2021 Drug cost: $505,540 (USD; Tot_Drug_Cst)2022 Drug cost: $481,302 (USD; Tot_Drug_Cst)2023 Drug cost: $535,040 (USD; Tot_Drug_Cst)2024 Drug cost: $1,035,921 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015249733$233,126
2016289837$342,251
2017299799$266,156
20183301,059$394,930
20193011,002$493,541
2020315977$570,710
2021324981$505,540
2022312800$481,302
2023321837$535,040
2024340990$1,035,921

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more130159$84
17110Destruction of skin growth, 1-14 growths99118$82
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more299377$58
17000Destruction of precancer skin growth, 1 growth191276$42
17003Destruction of precancer skin growth, 2-14 growths134723$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa11924$223,567
Dupixent SyringeDupilumab34952$127,868
Dupixent PenDupilumab23574$86,075
RinvoqUpadacitinib11330$74,540
Triamcinolone AcetonideTriamcinolone Acetonide2479,647$3,186

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Rachel Wenner Ruzanic, M.D.?

Tedicare shows public-source Medicare data for Rachel Wenner Ruzanic, M.D. (NPI 1073708608), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rachel Wenner Ruzanic, M.D. have ACO affiliation data?

Rachel Wenner Ruzanic, M.D. is shown with ACO affiliation data for Central Minnesota ACO, LLC (MSSP, ACO ID A2844).

What billing organization is linked to Rachel Wenner Ruzanic, M.D.?

Rachel Wenner Ruzanic, M.D. is linked to CENTRACARE CLINIC (billing NPI 1407858020) in the available physician profile data.

Does Rachel Wenner Ruzanic, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.